EvolutionaryScale Unveils ESM3 Generative AI Model for Advanced Protein Design
EvolutionaryScale has introduced its latest generative AI model, ESM3, which leverages NVIDIA H100 GPUs to enhance protein research and discovery. …
AI & Digital
14 Companies Pioneering AI Foundation Models in Pharma and Biotech
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As …
This Company Anonymized 1.8 Trillion Records to Support Biomedical Research
In the rapidly evolving life sciences and healthcare landscape, the secure and privacy-preserving exchange and linkage of health data is …
Basecamp Research Introduces ZymCTRL: An Open-Source AI Tool for Enzyme Design
Basecamp Research, in collaboration with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona, has introduced ZymCTRL, an …
13 Publicly Traded Biotechs Utilizing AI-based Research Platforms (+ 2 Upcoming Public Debuts)
According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences …
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
Toronto-based “techbio” company Deep Genomics has just annouced major milestones with the opening of a new office and lab facility …
New LENSai API by BioStrand Integrates Large Language Models with Health Data for Advanced Drug Development
BioStrand, a subsidiary of ImmunoPrecise Antibodies Ltd. (IPA), has launched its new LENSai API software, designed to integrate large databases …
Paige Introduces Multi-Modal AI for Enhanced Precision Oncology and Drug Discovery
Paige, a provider of digital pathology solutions and AI applications, has launched a new service line leveraging its Foundation Models. …
DeepCure Unveils AI-Driven Chemical Synthesis Platform
DeepCure, a company specializing in AI-driven therapeutic discovery, has introduced a development in chemical synthesis with its Inspired Chemistry™ platform. …
Owkin Expands Oncology Pipeline with AI and EP2/EP4 Dual Inhibitor from Idorsia
Owkin, a pioneering TechBio company leveraging advanced causal* AI for precision drug discovery, has announced a significant expansion of its …
Sanofi, Formation Bio, and OpenAI Partner to Innovate Drug Development with AI
Sanofi, Formation Bio, and OpenAI have announced a pioneering collaboration aimed at accelerating drug development using artificial intelligence (AI). This …
Insilico Medicine Unveils nach0: A Comprehensive LLM for Chemical and Biomedical Applications
Insilico Medicine, a clinical-stage AI-driven drug discovery company, in collaboration with NVIDIA, has introduced nach0, a novel large language model …